Currently out of the existing stock ratings of Charles Meade, 10 are a BUY (58.82%), 5 are a HOLD (29.41%), 2 are a SELL (11.76%).

Charles Meade

Work Performance Price Targets & Ratings Chart

Analyst Charles Meade, currently employed at JOHNSON RICE, carries an average stock price target met ratio of 64.81% that have a potential upside of 38.18% achieved within 258 days.

Charles Meade’s has documented 42 price targets and ratings displayed on 9 stocks. The coverage is on the Energy sector.

Most recent stock forecast was given on APA, APA at 05-Jan-2024.

Wall Street Analyst Charles Meade

Analyst best performing recommendations are on CTRA (COTERRA ENERGY).
The best stock recommendation documented was for DVN (DEVON ENERGY) at 3/8/2021. The price target of $37 was fulfilled within 226 days with a profit of $14.95 (67.8%) receiving and performance score of 3.

Average potential price target upside

DVN Devon Energy EOG EOG Resources SWN Southwestern Energy Company NOG Northern Oil & Gas COG Cabot Oil & Gas CTRA Coterra Energy BRY Berry Petroleum Corp FANG Diamondback Energy APA APA

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$57

$17.55 (44.49%)

$56

6 days ago
(18-Nov-2024)

7/25 (28%)

$18.22 (46.98%)

94

Buy

$49

$9.55 (24.21%)

$50

17 days ago
(07-Nov-2024)

4/12 (33.33%)

$9.99 (25.61%)

91

Buy

$43

$3.55 (9.00%)

$49

17 days ago
(07-Nov-2024)

14/30 (46.67%)

$3.99 (10.23%)

250

Buy

$62

$22.55 (57.16%)

$63

1 months 6 days ago
(18-Oct-2024)

8/14 (57.14%)

$21.34 (52.48%)

190

Hold

1 months 9 days ago
(15-Oct-2024)

4/4 (100%)

$4.8 (13.26%)

333

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Charles Meade?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?